These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21983344)

  • 1. Imperatorin prevents cardiac hypertrophy and the transition to heart failure via NO-dependent mechanisms in mice.
    Zhang Y; Cao Y; Duan H; Wang H; He L
    Fitoterapia; 2012 Jan; 83(1):60-6. PubMed ID: 21983344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Asanuma H; Minamino T; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Res; 2005 Mar; 65(4):879-88. PubMed ID: 15721868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo.
    Zhang Y; Cao Y; Zhan Y; Duan H; He L
    Fitoterapia; 2010 Dec; 81(8):1188-95. PubMed ID: 20691250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
    Liao Y; Takashima S; Asano Y; Asakura M; Ogai A; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Ogita H; Tomoike H; Hori M; Kitakaze M
    Circ Res; 2003 Oct; 93(8):759-66. PubMed ID: 12970111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
    Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
    Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
    J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dystrophin breakdown and endothelial nitric-oxide synthase uncoupling accounts for cytoprotection by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) in left ventricular hypertrophied Mice.
    Han F; Lu YM; Hasegawa H; Kanai H; Hachimura E; Shirasaki Y; Fukunaga K
    J Pharmacol Exp Ther; 2010 Feb; 332(2):421-8. PubMed ID: 19889795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways.
    Lin Y; Wang LN; Xi YH; Li HZ; Xiao FG; Zhao YJ; Tian Y; Yang BF; Xu CQ
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):124-30. PubMed ID: 18816294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
    Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
    Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
    Liao Y; Zhao H; Ogai A; Kato H; Asakura M; Kim J; Asanuma H; Minamino T; Takashima S; Kitakaze M
    Hypertens Res; 2008 Feb; 31(2):335-44. PubMed ID: 18360054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
    Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
    J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
    Zhang P; Xu X; Hu X; van Deel ED; Zhu G; Chen Y
    Circ Res; 2007 Apr; 100(7):1089-98. PubMed ID: 17363700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis.
    Kazakov A; Müller P; Jagoda P; Semenov A; Böhm M; Laufs U
    Cardiovasc Res; 2012 Mar; 93(3):397-405. PubMed ID: 22106415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle.
    Jankowski M; Wang D; Mukaddam-Daher S; Gutkowska J
    J Endocrinol; 2005 Jan; 184(1):209-17. PubMed ID: 15642797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
    Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
    Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression.
    Flaherty MP; Brown M; Grupp IL; Schultz JE; Murphree SS; Jones WK
    Cardiovasc Toxicol; 2007; 7(3):165-77. PubMed ID: 17901560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.